The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Professor Igor Pavlovich Nazarov

Read: 1283 times


To cite this article:

Professor Igor Pavlovich Nazarov. Russian Journal of Anesthesiology and Reanimatology. 2022;(6):122‑122. (In Russ.)
https://doi.org/10.17116/anaesthesiology2022061122

References:

  1. Yakhno NN, Shtulman DR. Bolezni nervnoj sistemy. V 2 t. (4-e izdanie). M.: Meditsina; 2005. (In Russ.).
  2. Tugasworo D, Kurnianto A, Retnaningsih, Andhitara Y, Ardhini R, Budiman J. The relationship between myasthenia gravis and COVID-19: A systematic review. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):83.  https://doi.org/10.1186/s41983-022-00516-3
  3. Heliopoulos I, Patlakas G, Vadikolias K, et al. Maximal voluntary ventilation in myasthenia gravis. Muscle Nerve. 2003;27(6):715-719.  https://doi.org/10.1002/mus.10378
  4. Galassi G, Marchioni A. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay. Acta Neurol Belg. 2021; 121(3):633-642.  https://doi.org/10.1007/s13760-021-01612-6
  5. Roper J, Fleming ME, Long B, Koyfman A. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department. J Emerg Med. 2017;53(6):843-853.  https://doi.org/10.1016/j.jemermed.2017.06.009
  6. Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res. 2020;21(1):198. Published 2020 July 28.  https://doi.org/10.1186/s12931-020-01462-5
  7. Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med. 2020;202(3):356-360.  https://doi.org/10.1164/rccm.202006-2157CP
  8. Neumann B, Angstwurm K, Mergenthaler P, et al. Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases [published correction appears in Neurology. 2020 Apr 21;94(16):724. Schneider, Haucke [corrected to Schneider, Hauke]]. Neurology. 2020;94(3):299-313.  https://doi.org/10.1212/WNL.0000000000008688
  9. International MG/COVID-19 Working Group, Jacob S, Muppidi S, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020;412:116803. https://doi.org/10.1016/j.jns.2020.116803
  10. Hoang P, Hurtubise B, Muppidi S. Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection. Neurology. 2020;95(18):840-843.  https://doi.org/10.1212/WNL.0000000000010651
  11. Heiman-Patterson T, Martino C, Rosenberg H, Fletcher J, Tahmoush A. Malignant hyperthermia in myotonia congenita. Neurology. 1988;38(5):810-812.  https://doi.org/10.1212/wnl.38.5.810
  12. Arcas M, Sánchez-Ortega JL, García-Muñoz M, Alonso B, del Yelmo F, López-Rodríguez F. Anestesia para cesárea en un caso de miotonía congénita [Anesthesia for cesarean delivery in a case of myotonia congenita]. Rev Esp Anestesiol Reanim. 1996;43(4):147-149. (In Spanish).
  13. Bisinotto FM, Fabri DC, Calçado MS, Perfeito PB, Tostes LV, Sousa GD. Anesthesia for videolaparoscopic cholecystectomy in a patient with Steinert disease. Case report and review of the literature. Rev Bras Anestesiol. 2010;60(2):181-110.  https://doi.org/10.1016/s0034-7094(10)70024-6
  14. Haeseler G, Störmer M, Bufler J, et al. Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg. 2001;92(5):1192-1198. https://doi.org/10.1097/00000539-200105000-00021
  15. Haeseler G, Störmer M, Mohammadi B, et al. The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels. Muscle Nerve. 2001;24(6):736-743.  https://doi.org/10.1002/mus.1064
  16. Weller JF, Elliott RA, Pronovost PJ. Spinal anesthesia for a patient with familial hyperkalemic periodic paralysis. Anesthesiology. 2002;97(1):259-260.  https://doi.org/10.1097/00000542-200207000-00033
  17. Allison KR. Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child. Paediatr Anaesth. 2007;17(1):1-6.  https://doi.org/10.1111/j.1460-9592.2006.02106.x
  18. Flewellen EH, Bodensteiner JB: Anesthetic experience in a patient with hyperkalemic periodic paralysis. Anesth Rev. 1980;7:44. 
  19. Viscomi CM, Ptacek LJ, Dudley D. Anesthetic management of familial hypokalemic periodic paralysis during parturition. Anesth Analg. 1999;88(5):1081-1082. https://doi.org/10.1097/00000539-199905000-00021
  20. Siler JN, Discavage WJ. Anesthetic management of hypokalemic periodic paralysis. Anesthesiology. 1975;43(4):489-490.  https://doi.org/10.1097/00000542-197510000-00018
  21. Löfgren A, Hahn RG. Hypokalemia from intercostal nerve block. Reg Anesth. 1994;19(4):247-254. 
  22. Zisfein J, Sivak M, Aron AM, Bender AN. Isaacs’ syndrome with muscle hypertrophy reversed by phenytoin therapy. Arch Neurol. 1983;40(4):241-242.  https://doi.org/10.1001/archneur.1983.04050040071012
  23. Van den Berg JS, van Engelen BG, Boerman RH, de Baets MH. Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin. J Neurol. 1999;246(7):623-625.  https://doi.org/10.1007/s004150050419
  24. Ashizawa T, Butler IJ, Harati Y, Roongta SM. A dominantly inherited syndrome with continuous motor neuron discharges. Ann Neurol. 1983;13(3):285-290.  https://doi.org/10.1002/ana.410130310
  25. Hosokawa S, Shinoda H, Sakai T, Kato M, Kuroiwa Y. Electrophysiological study on limb myokymia in three women. J Neurol Neurosurg Psychiatry. 1987;50(7):877-881.  https://doi.org/10.1136/jnnp.50.7.877
  26. Morgan PJ. Peripartum management of a patient with Isaacs’ syndrome. Can J Anaesth. 1997;44(11):1174-1177. https://doi.org/10.1007/BF03013340
  27. McNicol ED, Tzortzopoulou A, Cepeda MS, Francia MB, Farhat T, Schumann R. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and meta-analysis. Br J Anaesth. 2011;106(6):764-775.  https://doi.org/10.1093/bja/aer107
  28. Birnkrant DJ, Panitch HB, Benditt JO, et al. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest. 2007;132(6):1977-1986. https://doi.org/10.1378/chest.07-0458
  29. Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: A systematic review. Br J Anaesth. 2011;106(3):292-297.  https://doi.org/10.1093/bja/aeq406
  30. Fowler SJ, Symons J, Sabato S, Myles PS. Epidural analgesia compared with peripheral nerve blockade after major knee surgery: A systematic review and meta-analysis of randomized trials. Br J Anaesth. 2008;100(2):154-164.  https://doi.org/10.1093/bja/aem373
  31. Walker KJ, McGrattan K, Aas-Eng K, Smith AF. Ultrasound guidance for peripheral nerve blockade. Cochrane Database Syst Rev. 2009;(4):CD006459. Published 2009 Oct 7.  https://doi.org/10.1002/14651858.CD006459.pub2
  32. Niranjan V, Bach JR. Noninvasive management of pediatric neuromuscular ventilatory failure. Crit Care Med. 1998;26(12):2061-2065. https://doi.org/10.1097/00003246-199812000-00042
  33. Ruscic KJ, Grabitz SD, Rudolph MI, Eikermann M. Prevention of respiratory complications of the surgical patient: actionable plan for continued process improvement. Curr Opin Anaesthesiol. 2017;30(3):399-408.  https://doi.org/10.1097/ACO.0000000000000465
  34. Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027-1049. https://doi.org/10.1177/0883073807305788
  35. Almenrader N, Patel D. Spinal fusion surgery in children with non-idiopathic scoliosis: is there a need for routine postoperative ventilation? Br J Anaesth. 2006;97(6):851-857.  https://doi.org/10.1093/bja/ael273
  36. Marchant WA, Fox R. Postoperative use of a cough-assist device in avoiding prolonged intubation. Br J Anaesth. 2002;89(4):644-647.  https://doi.org/10.1093/bja/aef227
  37. Lebedinskii KM, Triadsky AA, Obolensky SV. Malignant hyperthermia: a pharmacogenetic caused by acute massive rhabdomyolysis. Anesteziologiya i Reanimatologiya. 2008;4:66-70. (In Russ.).
  38. Wang CH, Bonnemann CG, Rutkowski A, et al. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol. 2010;25(12):1559-1581. https://doi.org/10.1177/0883073810381924
  39. Bach JR, Gonçalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: A new management paradigm. Chest. 2010;137(5): 1033-1039. https://doi.org/10.1378/chest.09-2144
  40. Miranda Rocha AR, Martinez BP, Maldaner da Silva VZ, Forgiarini Junior LA. Early mobilization: Why, what for and how? Med Intensiva. 2017;41(7):429-436.  https://doi.org/10.1016/j.medin.2016.10.003
  41. Belkin AA, Alasheev AM, Belkin VA, et al. Rehabilitation in the intensive care unit (RehabICU). Clinical practice recommendations of the national Union of Physical and Rehabilitation Medicine Specialists of Russia and of the national Federation of Anesthesiologists and Reanimatologists. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of Critical Care. 2022;2:7-40. (In Russ). https://doi.org/10.21320/1818-474X-2022-2-7-40
  42. Shousha AA, Sanfilippo M, Sabba A, Pinchera P. Sugammadex and reversal of neuromuscular block in adult patient with duchenne muscular dystrophy. Case Rep Anesthesiol. 2014;2014:680568. https://doi.org/10.1155/2014/680568
  43. Shimauchi T, Yamaura K, Sugibe S, Hoka S. Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy. Acta Anaesthesiol Taiwan. 2014;52(3):146-148.  https://doi.org/10.1016/j.aat.2014.02.005
  44. De Boer HD, Van Egmond J, Driessen JJ, Booij LHJD. Sugammadex in patients with myasthenia gravis. Anaesthesia. 2010;65(6):653.  https://doi.org/10.1111/j.1365-2044.2010.06360.x
  45. Jakubiak J, Gaszyński T, Gaszyński W. Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis. Anaesthesiol Intensive Ther. 2012;44(1):28-30. 
  46. Sungur Ulke Z, Yavru A, Camci E, Ozkan B, Toker A, Senturk M. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy. Acta Anaesthesiol Scand. 2013;57(6):745-748.  https://doi.org/10.1111/aas.12123
  47. Vymazal T, Krecmerova M, Bicek V, Lischke R. Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery — a series of 117 cases. Ther Clin Risk Manag. 2015;11:1593-1596. Published 2015 Oct 15.  https://doi.org/10.2147/TCRM.S93009
  48. Sungur Z, Sentürk M. Anaesthesia for thymectomy in adult and juvenile myasthenic patients. Curr Opin Anaesthesiol. 2016;29(1):14-19.  https://doi.org/10.1097/ACO.0000000000000272
  49. Ortiz-Gómez JR, Palacio-Abizanda FJ, Fornet-Ruiz I. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: A case report. Eur J Anaesthesiol. 2014;31(12):708-709.  https://doi.org/10.1097/EJA.0000000000000082
  50. Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.